|
GOLGA4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.97879998234896E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.70129999480062E-08 |
| Normal-vs-Stage2 |
4.417000E-04 |
| Normal-vs-Stage3 |
7.50809999727764E-08 |
| Normal-vs-Stage4 |
3.56479999963355E-07 |
| Stage1-vs-Stage2 |
4.853600E-01 |
| Stage1-vs-Stage3 |
2.943600E-01 |
| Stage1-vs-Stage4 |
6.350300E-02 |
| Stage2-vs-Stage3 |
8.660200E-01 |
| Stage2-vs-Stage4 |
4.645200E-01 |
| Stage3-vs-Stage4 |
5.096200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.24520002379114E-09 |
| Normal-vs-AfricanAmerican |
3.80300000002443E-06 |
| Normal-vs-Asian |
3.656700E-03 |
| Caucasian-vs-AfricanAmerican |
7.708200E-01 |
| Caucasian-vs-Asian |
9.329800E-01 |
| AfricanAmerican-vs-Asian |
9.750800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.06879965883411E-10 |
| Normal-vs-Female |
3.419800E-03 |
| Male-vs-Female |
7.656800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.388700E-04 |
| Normal-vs-Extreme_Weight |
6.82269796214996E-11 |
| Normal-vs-Obese |
1.22950000003286E-06 |
| Normal-vs-Extreme_Obese |
3.602600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.222200E-01 |
| Normal_Weight-vs-Obese |
9.493600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.015200E-01 |
| Extreme_Weight-vs-Obese |
1.015410E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.568180E-02 |
| Obese-vs-Extreme_Obese |
1.666170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.126150E-02 |
| Normal-vs-Age(41-60Yrs) |
2.97369999735508E-08 |
| Normal-vs-Age(61-80Yrs) |
6.44849995623531E-09 |
| Normal-vs-Age(81-100Yrs) |
4.961200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.160600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.784050E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.159000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.238200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.825600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.088800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.7698000054931E-08 |
| Normal-VS-Type2 PRCC |
1.63492999999404E-05 |
| Normal-VS-KIRP CIMP |
2.797400E-03 |
| Normal-VS-Unclassified PRCC |
1.969310E-04 |
| Type1 PRCC-VS-Type2 PRCC |
9.875600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.559800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.594600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.121600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.600200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.791400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.44419998182599E-09 |
| Normal-vs-N1 |
1.48749999995257E-06 |
| Normal-vs-N2 |
3.574600E-04 |
| N0-vs-N1 |
7.390800E-01 |
| N0-vs-N2 |
6.348600E-01 |
| N1-vs-N2 |
5.357800E-01 |
|
|
